Afuco™ Anti-Human FCRL2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-FCRL2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies that specifically bind to IRTA-4 with high affinity can be used for treating various B cell malignancies, including non-Hodgkin's lymphoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-260CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FCRL2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |